Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive
Global - Asia
Archived
•
July 22, 2026
•
US President Donald Trump on Tuesday announced the final stage of his pharmaceutical tariff plan, under which imported generic medicines will continue to enter the US without duties until August 1, 2028.
Source: https://timesofindia.indiatimes.com/rssfeedstopstories.cms - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
